micronisation

micronisation
Product Description

More than twenty years’ experience in micronisation.  Inke is able to provide solutions for early market entry opportunities or for products requiring in-depth knowledge of micronisation techniques.
Our experience in in-house micronisation technology at Inke means we can provide:

·       Isolation, final treatment and analysis of active ingredients for use in respiratory therapies performed in special containment facilities

·       Process control of micronisation grades achieved to ensure that each active ingredient conforms to custom particle size distribution specifications

·       Control of amorphous content and other relevant parameters for particle size stability for suitable formulation purposes

·       Customised products and technical support

·       Various patent applications

Inke S.A.

  • ES
  • 2017
    On CPHI since
  • 100 - 249
    Employees
Company types
Other
Specifications

Inke S.A.

  • ES
  • 2017
    On CPHI since
  • 100 - 249
    Employees
Company types
Other

More Products from Inke S.A. (45)

  • Tolvaptan

    Product Tolvaptan

    Inke (API manufacturer) part of the  Neuraxpharm, provides wide range of APIs which includes Tolvaptan. Indication: Hiponatremia. 
  • Umeclidinium

    Product Umeclidinium

    Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Umeclidinium for COPD 
  • Vilanterol

    Product Vilanterol

    Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Vilanterol Trifenatate for Asthma and COPD 
  • Zolmitriptan

    Product Zolmitriptan

    Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Zolmitriptan. Indication: Migraine

    EU-US DMF
  • Benserazide

    Product Benserazide

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Benserazide. Indication for Parkinson's disease
  • Inhalation APIs

    Product Inhalation APIs

    ARFORMOTEROL, FORMOTEROL, GLYCOPYRROLATE,  INDACATEROL, OLODATEROL SALMETEROL, TIOTROPIUM, UMECLIDINIUM and VILANTEROL

  • Otilonium bromide

    Product Otilonium bromide

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Otilonium bromide for treating irritable bowel syndrome

    EU DMF

  • Paliperidone Palmitate

    Product Paliperidone Palmitate

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Paliperidone indicated for schizophrenia and bipolar disorder
  • Pipamperone

    Product Pipamperone

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Pipamperone for treating schizophrenia
  • Tafamidis

    Product Tafamidis

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Tafamidis for Trnsthyretin amyloidosis


  • Aclidinium bromide

    Product Aclidinium bromide

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aclidinium. Indication: COPD treatment
  • Aprepitant

    Product Aprepitant

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aprepitant. Indication: Emesis

Inke S.A. resources (1)

  • Brochure INKE PORTFOLIO AND PIPELINE

    Inke is a Barcelona-based company with an FDA approved plant, we develop and manufacture APIs with complex synthesis process mostly for Respiratory diseases (Inhalation) and also CNS , among other therapeutically areas.

     
    INKE has several DMFs approved already in the US-FDA and we are already supplying to some local and multinational pharmaceutical companies worldwide.